Select Page

Catalyzing Ontario’s Life Sciences Economy: Urgent Call to Bridge the Risk Capital Gap

Ontario’s life sciences sector is a global leader in research and talent—but a critical shortage of seed-stage capital is limiting its ability to commercialize innovation and retain homegrown companies. A new report from Life Sciences Ontario and Shift Health outlines the urgency of this challenge and presents a clear roadmap for change.

More

Curating the Cabinet

We share key insights for pharmaceutical companies bringing new products to the Canadian market, highlighting considerations for the current and future hospital formulary decision-making landscape.

More